INCY:NASDAQ
Incyte Corp
$112.86
arrow_downward
-1.11%(-1.27) 1D
Oct 6, 1:15:50 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$114.13
High
$114.97
Low
$111.67
Mkt. cap
23.11B
Avg. vol.
1.50M
Volume
1.14M
P/E ratio
14.38
52-wk high
$132.60
52-wk low
$82.82
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
Open
$114.13
High
$114.97
Low
$111.67
Mkt. cap
23.11B
Avg. vol.
1.50M
Volume
1.14M
P/E ratio
14.38
52-wk high
$132.60
52-wk low
$82.82
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
5 hours ago
Incyte stock gets a USD 157 Stifel price target after pipeline update
Kalkine Media
·
7 hours ago
What Will Decide the Next Move in Incyte (NASDAQ:INCY)?
Kalkine Media
·
7 hours ago
Incyte (NASDAQ:INCY) Races to Build Beyond Jakafi
AD HOC NEWS
·
19 hours ago
Incyte stock after-hours at EUR 100.70: minus 1.71 percent
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com